• UK Rare Diseases Framework Opens to Improve Diagnosis, Access to Care
  • Cholesterol Metabolism Impaired in CF Mouse Model
  • Phase 1/2 Trial to Test Phage Therapy for Chronic P. aeruginosa Infections
  • NORD Seeks Speakers for 2021 Virtual ‘Living Rare, Living Stronger’ Forum
  • CF Foundation Hosts COVID-19 Vaccine Panel Talk, Q&A on Thursday
  • Study Examines Effects of Socioeconomics on Health of Youngsters
  • Inhaled-IV Antibiotic Combo May Better Treat Acute Flares Than IV-only Mix
  • Fecal Protein Tied to Worse GI Symptoms, Quality of Life in CF Children
  • Health Canada Giving Priority Review to Trikafta
  • Arcturus to Develop ARCT-032 as RNA Therapy for CF
  • Small Study Shows Tobramycin Safely Treats Lung Infection in Infants With CF
  • I Am a Lung Transplant Recipient, and I Had COVID-19